FDA Suppresses Suprenza Site, But Coupon Link Remains
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA sends untitled letter to Citius Pharmaceuticals and licensee Akrimax for not including any risk information on webpage for weight loss product; Akrimax received a similar citation in March for a Tirosint Facebook page.